Therapeutic and adverse effects of standard-dose and low-dose meglumine antimoniate during systemic treatment of Syrian cutaneous leishmaniasis patients. Journal of Pakistan Association of Dermatologists, [S. l.], v. 24, n. 2, p. 115–121, 2016. DOI: 10.66344/jpad.v24i2.189. Disponível em: https://www.jpad.com.pk/index.php/jpad/article/view/189. Acesso em: 28 jul. 2026.